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Abstract: Endothelial cell injury and subsequent death play an essential role in the pathogenesis of atherosclerosis.
Autophagy of endothelial cells antagonizes the development of atherosclerosis, whereas the underlying molecu-
lar mechanisms are unclear. MicroRNA-129-5p (miR-129-5p) is a well-defined tumor suppressorin some types of 
cancer, while it is unknown whether miR-129-5p may also play a role in the development of atherosclerosis. Here, 
we addressed this question in the current study. We examined the levels of endothelial cell autophagy in ApoE (-/-) 
mice suppled with high-fat diet (HFD), a mouse model for atherosclerosis (simplified as HFD mice). We analyzed the 
levels of Beclin-1 and the levels of miR-129-5p in the purified CD31+ endothelial cells from mouse aorta. Predic-
tion of the binding between miR-129-5p and 3’-UTR of Beclin-1 mRNA was performed by bioinformatics analyses 
and confirmed by a dual luciferase reporter assay. The effects of miR-129-5p were further analyzed in an in vitro 
model using oxidized low-density lipoprotein (ox-LDL)-treated human aortic endothelial cells (HAECs). We found that 
HFD mice developed atherosclerosisin 12 weeks, while the control ApoE (-/-) mice that had received normal diet 
(simplified as CTL mice) did not. Compared to CTL mice, HFD mice had significantly lower levels of endothelial cell 
autophagy, resulting from decreases in Beclin-1 protein, but not mRNA. The decreases in Beclin-1 in endothelial 
cells were due to HFD-induced increases inmiR-129-5p, which suppressed the translation of Beclin-1 mRNA via 3’-
UTR binding. These in vivo findings were reproduced in vitro on ox-LDL-treated HAECs. Together, these data suggest 
that upregulation of miR-129-5p by HFD may impair the protective effects of endothelial cell autophagy against 
development of atherosclerosis through suppressing protein translation of Beclin-1. 
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Introduction
Atherosclerosis is a chronic inflammatory dis-
ease in which lipids and fibrous elements are 
deposited in the arterial wall large and medi-
um-sized arteries to activate both the innate 
and adaptive immune systems. Atherosclerosis 
is the primary cause of heart disease and 
stroke, which accounts for more than half of all 
deaths in aged people [1, 2]. The progression of 
atherosclerosis includes early accumulation of 
cholesterol-engorged macrophages in the sub-
endothelial matrix, accumulation of lipid-rich 
necrotic debris, elevated numbers of smooth 
muscle cells (SMCs), and subsequent develop-
ment of fibrosis, which lead to formation of 
complex plaques with calcification, ulceration 
and hemorrhage eventually [1, 2]. 
Apolipoprotein E (ApoE) is a 34-kDa secreted 
protein, as a well-known strong suppressor for 
atherosclerosis [3, 4]. ApoE not only regulates 
lipoprotein cholesterol transport and controls 
cellular lipid regulation, but also potently inhib-
its inflammation [3, 4]. For example, ApoE-
deficient (ApoE -/-) mice display enhanced 
chronic inflammation in response to spontane-
ous and diet-induced hypercholesterolemia, 
and display enhanced acute immune response 
when challenged with bacterial lipopolysaccha-
ride (LPS) [3-9]. High fat diet (HFD) induces 
development of atherosclerosis in ApoE -/- mice 
in 12 weeks [10-12].
Endothelial cell injury is a major step for the 
pathological progression of atherosclerosis [13-
17]. Upon injury, endothelial cell autophagy may 
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occur to protect the cells from being damaged, 
while the failure or inhibition of autophagy 
results in endothelial cell apoptosis, leading to 
the break-down of the integrity of endothelium 
to facilitate the local lipid deposition into ath-
erogenesis, plaque instability, and even acute 
coronary occlusion and sudden death [13, 
18-23]. Nevertheless, our understanding of the 
mechanisms that control the autophagy of 
endothelial cells is still limited.
Autophagy is a catabolic pathway that degrades 
and recycles cellular compartments for cell sur-
vival at various stresses, whereas its failure 
often leads to cell death [24]. Microtubule-
associated protein 1A/1B-light chain 3 (LC3) is 
a soluble cellular protein. During autophagy, 
autophagosomes engulf cytoplasmic compo-
nents, resulting in conjugation of a cytosolic 
form of LC3 (LC3-I) to phosphatidylethanol-
amine to form LC3-phosphatidylethanolamine 
conjugate (LC3-II). Thus, the ratio of LC3-II to 
LC3-I represents the autophagic activity [24-
26]. Beclin-1, ATG7 and ATG5 are several key 
autophagy-associated proteins that strongly 
induce autophagy in an independent or coordi-
nated manner [27]. Autophagy has been shown 
to play a critical role in endothelial cells to pre-
vent development of atherosclerosis [13, 
18-23]. Nevertheless, the underlying mecha-
nisms have not been completely elucidated.
MicroRNAs (miRNAs) are small non-coding 
RNAs that regulate protein translation through 
their base-pairing with the 3’-untranslated 
region (3’-UTR) of the target mRNAs. MiRNAs 
play essential roles in regulating atherosclero-
sis [5, 28, 29]. Among all miRNAs, miR-129-5p 
has been shown to suppress carcinogenesis of 
various cancers [30-38]. Nevertheless, a role 
of miR-129-5p in the atherosclerosis has not 
been studied. 
Here, we found that high-fat-diet (HFD) -treated 
ApoE (-/-) mice developed atherosclerosis in 12 
weeks, while the control ApoE (-/-) mice that 
had received normal diet (simplified as CTL 
mice) did not. Compared to CTL mice, HFD mice 
had significantly lower levels of endothelial cell 
autophagy, resulting from decreases in Beclin-1 
protein, but not mRNA. The decreases in 
Beclin-1 in endothelial cells were due to HFD-
induced increases in miR-129-5p, which sup-
pressed the translation of Beclin-1 mRNA via 
3’-UTR binding. These in vivo findings were 
reproduced in vitro on oxidized low-density lipo-
protein (ox-LDL)-treated human aortic endothe-
lial cells (HAECs).
Materials and methods
Animal models and quantification of athero-
sclerotic lesions
The study was approved by the Animal Care and 
Use Committee of Third Military Medical 
University. All experimental procedures were 
performed in accordance with the Guide for the 
Care and Use of Laboratory Animals, published 
by the US National Institutes of Health. All 
experiments were conducted under the super-
vision of the facility’s Institutional Animal Care 
and Use Committee according to an Institutional 
Animal Care and Use Committee-approved pro-
tocol. Ten-week-old male ApoE -/- mice were 
purchased from Jackson Laboratory (Bar 
Harbor, ME, USA) or bred in-house and main-
tained under sterile conditions and standard 
animal room conditions (temperature, 21 ± 
1°C; humidity, 55-60%). The animals were ran-
domly divided into two groups: the normal-diet 
group (CTL) and the high-fatdiet (HFD) group. 
The animals of the HFD group were maintained 
for 12 weeks to induce atherosclerosis, after 
which the aortas were excised from the mice. 
The aortic roots along with the basal portion of 
the heart were fixed with 4% paraformaldehyde 
for 4 hours, cryo-protected in 30% sucrose for 
12 hours, and then embedded in OCT com-
pound. The tissue was cross-sectioned into 
sections of 6 μm thickness. Atherosclerotic 
lesions of the aortic root were examined by 
H&E staining. Oil red O staining was performed 
according to the manufacturer’s instructions to 
show the lipid deposition with an Oil red O stain-
ing kit (Abcam, Cambridge, MA, USA). 
Quantification of the images was measured 
using NIH ImageJ software (Bethesda, MD, 
USA). The data were calculated from 5 mice for 
each group. For each mouse, 3 slides that were 
20 µm apart from each other were used for 
quantification.
Cell culture, treatment and transfection
Normal human aortic endothelial cells (HAECs) 
were purchased from American Type Culture 
Collection (ATCC PCS-100-011, Rockville, MD, 
USA) and cultured in Endothelial Cell Media 
supplemented with endothelial cell growth fac-
tors, 5% fetal bovine serum (FBS, Invitrogen, 
CA, Carlsbad, USA) and 1% penicillin/strepto-
mycin (Invitrogen) at 37°C with 5% CO2. HAECs 
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were transiently transfected with miR-129-5p 
mimics, antisense for miR-129-5p (as-miR-
129-5p) or null controls (RiboBio Co., Ltd., 
Guangzhou, Guangdong, China), using Lipo- 
fectamine 2000 reagent (Invitrogen), according 
to the manufacturer’s instructions. The trans-
fection efficiency was nearly 100%. One day 
after cell transfection, the cells were treated 
with or without 100 µg/ml oxidized low-density 
lipoprotein (ox-LDL, Beijing Xiesheng Bio-
Technology Limited, Beijing, China). After drug 
treatment, the cells were used for flow cytome-
try or protein/RNA extraction.
Cell counting kit-8 (CCK-8) assay
The CCK-8 detection kit (Sigma-Aldrich, St. 
Louis, MO, USA) was used to measure cell via-
bility according to the manufacturer’s instruc-
tions. Briefly, cells were seeded in a 96-well 
microplate at a density of 5×104/ml. After 24 h, 
cells were treated with resveratrol. Subse- 
quently, CCK-8 solution (20 ml/well) was added 
and the plate was incubated at 37°C for 2 
hours. The viable cells were counted by absor-
bance measurements with a monochromator 
microplate reader at a wavelength of 450 nm. 
The optical density value was reported as the 
percentage of cell viability in relation to the con-
trol group (set as 100%).
Flow cytometry
For analyses and isolation of CD31+ cells, the 
aorta was dissociated by 10 μg/ml trypsin 
(Sigma-Aldrich) and 10 μg/ml DNase (Roche, 
Nutley, NJ, USA) for 35 minutes. After filtration 
at 30 μm, the single cell digests from mouse 
aorta were incubated with PE-cy7-CD31 
(Becton-Dickinson Biosciences, San Jose, CA, 
USA) and then sorted on a FACSAria (Becton-
Dickinson Biosciences).
Quantitative RT-PCR
Aorta intimal RNA was isolated from mouse 
aortas. After cleaning with ice-cold PBS, mouse 
aortas were flushed with TRIzol reagent 
(Invitrogen) using an insulin syringe, and the 
eluate was collected in a 1.5 ml tube and pre-
pared for RNA extraction. Total RNA and miR-
NAs were extracted from tissue or cultured 
cells with miRNeasy mini kit or RNeasy kit 
(Qiagen, Hilden, Germany), respectively. 
Complementary DNA (cDNA) was randomly 
primed from 2 μg of total RNA using High-
Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems, Foster City, CA, USA). 
RT-qPCR was subsequently performed in tripli-
cate with QuantiTect SYBR Green PCR Kit 
(Qiagen). All primers were purchased from 
Qiagen. Data were collected and analyzed 
using 2-ΔΔCt method for quantification of the 
relative mRNA expression levels. Values of 
genes were first normalized against α-tubulin, 
and then compared to the experimental 
controls.
Western blotting
The cells were lysed with RIPA buffer containing 
protease and phosphatase inhibitors (cOm-
plete ULTRA Tablets, Roche, Nutley, NJ, USA). 
After centrifugation, the supernatant was col-
lected and quantified. The proteins were then 
separated by SDS-PAGE and transferred to 
nitrocellulose membranes. After blocking with 
5% non-fat milk, the membranes were probed 
with rat anti-CD31 (Becton-Dickinson Bio- 
sciences), rabbitanti-ATG5, rabbit anti-LC3, rab-
bit-anti-Beclin-1, rabbit-anti-ATG7 and rabbit-
anti-α-tubulin (Cell Signaling Technology, Dan- 
vers, MA, USA). Secondary antibodiesare HRP-
conjugated against rat or rabbit (Jackson 
ImmunoResearch Labs, West Grove, PA, USA). 
The protein levels were first normalized to 
α-tubulin, and then normalized to the experi-
mental controls. Densitometry of Western blots 
was quantified with NIH ImageJ software.
MiRNA target prediction and 3’-UTR luciferase-
reporter assay 
MiRNAs targets were predicted as has been 
described before, using the algorithms 
TargetSan (https://www.targetscan.org) [39]. 
The Beclin-1 3’-UTR reporter plasmid (pRL-
Beclin-1) was purchased from Creative Biogene 
(Shirley, NY, USA). MiR-129-5p-modified HAECs 
were transfected with 0.5 μg pRL-Beclin-1 by 
Lipofectamine 2000 (5×104 cells per well). 
Cells were collected 48 hours after transfec-
tion for assay using the dual-luciferase reporter 
assay system gene assay kit (Promega, 
Madison, WI, USA), according to the manufac-
turer’s instructions.
Statistical analyses
The data in this study are shown as the mean ± 
S.D. Differences among groups were analyzed 
using one-away ANOVA with a Bonferroni cor-
rection, followed by Fisher’ Exact Test for com-
parison of two groups (GraphPad Prism, 
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GraphPad Software, Inc. La Jolla, CA, USA). 
p<0.05 was considered significant.
Result
HFD induces atherosclerosis in ApoE (-/-) mice 
Here, we gave a high-fat diet (HFD) to treat 
ApoE (-/-) mice (simplified as HFD mice) to 
induce experimental atherosclerosis in 12 
weeks, which was confirmed by increases in 
aortic lesion size (Figure 1A), and by increases 
in lipid content in aortic sinus (Figure 1B), com-
pared to littermate ApoE (-/-) mice that had 
received normal diet (CTL) as a control. Thus, 
HFD induces atherosclerosis in ApoE (-/-) mice. 
In order to analyze endothelial cells, we dissoci-
ated mouse aorta and purified endothelial cells 
based on CD31 labeling by flow cytometry 
(Figure 1C). 
HFD impairs endothelial cell autophagy in 
ApoE (-/-) mice
Then we analyzed the autophagy levels in endo-
thelial cells from HFD and CTL mice. We found 
that the LC3-II/I ratio significantly decreased in 
endothelial cells from HFD mice, than those 
pared to those from CTL mice (Figure 2F). 
These data suggest that the effects of HFD on 
endothelial cell Beclin-1 may be through post-
transcriptional control.
HFD impairs endothelial cell autophagy in 
ApoE (-/-) mice through suppressing the trans-
lation of Beclin-1 mRNA by miR-129-5p
Next, we examined the underlying mechanisms. 
Since post-transcriptional control of gene 
expression is usually regulated miRNAs, we 
used bioinformatics analyses to screenallmiR-
NAs that target Beclin-1 and altered their levels 
in endothelial cells in HFD mice. Specifically, we 
found that miR-129-5p targets 3’-UTR of 
Beclin-1 mRNA at one binding site of base pair 
97th to 106th (Figure 3A). Moreover, miR-129-
5p levels in endothelial cells significantly 
increased after HFD treatment (Figure 3B). 
Hence, we modified miR-129-5p levels in 
human aortic endothelial cells (HAECs), by 
transfection of the cells with miR-129-5p mim-
ics, antisense for miR-129-5p (as-miR-129-5p) 
or null controls (null). First, modification of miR-
129-5p levels in HAECs was confirmed by 
RT-qPCR (Figure 3C). Next, the intact 3’-UTR of 
Figure 1. HFD induces atherosclerosis in ApoE (-/-) mice. We used ApoE 
(-/-) mice treated with high-fat diet (HFD; simplified as HFD mice) for analyz-
ing endothelial cell apoptosis. ApoE (-/-) mice that had received normal diet 
(CTL) were used as a control. (A, B) After a 12-week HFD treatment, analysis 
of H&E-stained histological sections of the aortic sinus showed a significant 
increase in aortic lesion size (A), and analysis of Oil-red-O-stained histologi-
cal sections of the aortic sinus showed a significant increase in lipid content 
(B). (C) The aortas were dissociated and purified for endothelial cells based 
on CD31 labeling by flow cytometry. *p<0.05. N=5.
from CTL mice, shown by rep-
resentative immunoblots (Fig- 
ure 2A), and by quantification 
(Figure 2B). Then we analyzed 
the levels of major autophagy-
activators ATG7, ATG5 and 
Beclin-1 in endothelial cells 
from these mice, and found 
no difference in the levels of 
ATG7 and ATG5 between 
endothelial cells from HFD 
and CTL mice, shown by repre-
sentative immunoblots (Fig- 
ure 2A), and by quantification 
(Figure 2C, 2D). However, we 
detected a significant de- 
crease in the levels of Beclin-1 
in endothelial cells from HFD 
mice, compared to those from 
CTL mice, shown by represen-
tative immunoblots (Figure 
2A), and by quantification 
(Figure 2E). These data sug-
gest that HFD may inhibit 
Beclin-1 to impair endothelial 
cell autophagy. Interestingly, 
the mRNA level of Beclin-1 
was not altered in endothelial 
cells from HFD mice, com-
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Beclin-1 mRNA was cloned 
into a luciferase reporter plas-
mid, and used for transfec- 
tion of miR-129-5p-modified 
HAECs. We found that miR-
129-5p significantly reduced 
the luciferase activity of 
3’-UTR reporter for Beclin-1, 
Figure 2. HFD impairs endothelial cell autophagy in ApoE (-/-) mice. (A-E) Immunoblots for apoptosis-associated 
genes LC3-II/I, ATG7, ATG5 and Beclin-1 in endothelial cells from HFD and CTL mice, shown by representative blots 
(A), and by quantification for LC3-II/I (B), ATG7 (C), ATG5 (D) and Beclin-1 (E). (F) RT-qPCR for mRNA of Beclin-1. 
*p<0.05. NS: non-significant. N=5.
Figure 3. HFD impairs endothelial cell autophagy in ApoE (-/-) mice through 
suppressing the translation of Beclin-1 mRNA by miR-129-5p. A. Bioinfor-
matics analyses showing that miR-129-5p targets 3’-UTR of Beclin-1 mRNA 
at one binding site of base pair 2820th to 2826th. B. MiR-129-5p levels in 
endothelial cells from HFD or 
CTL mice. C. RT-qPCR for miR30 
in miR-129-5p-modified human 
aortic endothelial cells (HAECs), 
prepared by transfection of the 
cells with miR-129-5p mimics, 
antisense for miR-129-5p (as-
miR-129-5p) or null controls 
(null). D. The intact 3’UTR of Be-
clin-1 mRNA was cloned into a 
luciferase reporter plasmid, and 
used for transfection of miR-
129-5p-modified HAECs. The 
luciferase activities were quanti-
fied. *p<0.05. N=5.
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while as-miR-129-5p significantly increased the 
luciferase activity of 3’-UTR reporter for 
Beclin-1, compared to null control (Figure 3D). 
Together, these data suggest that HFD impairs 
endothelial cell autophagy in ApoE (-/-) mice 
through suppressing the translation of Beclin-1 
mRNA by miR-129-5p. 
Ox-LDL-treatmentsimilarly impairs cell autoph-
agy in HAECs
To confirm the findings in HFDmice, we used an 
in vitro model of atherosclerosis, in which 
HAECs were treated with or without 100 µg/ml 
oxidized low-density lipoprotein (ox-LDL) to 
induce cell injury similar to in vivo model. First, 
we confirmed that ox-LDL treatment resulted in 
a significant reduction in viable cell number in 
an CCK-8 assay (Figure 4A). Moreover, ox-LDL 
significantly decreased the ratio of LC3II/I and 
Beclin-1levels (Figure 4B, 4D), without altering 
Beclin-1mRNA (Figure 4E). Finally, the levels of 
miR-129-5p were significantly increased by ox-
LDL (Figure 4F). Together, these data suggest 
that ox-LDL-treated HAECs reproduceour find-
Figure 4. Ox-LDL-treatment similarly impairs cell autophagy in HAECs. To confirm the findings in HFD mice, we used 
an in vitro model of atherosclerosis, in which HAECs were treated with or without 100 µg/ml oxidized low-density 
lipoprotein (ox-LDL). (A) Quantification of viable cell number in an CCK-8 assay. (B-E) Immunoblots for apoptosis-
associated genes LC3-II/I and Beclin-1 in endothelial cells from HFD and CTL mice, shown by representative blots 
(B), and by quantification for LC3-II/I (C) and Beclin-1 (D). (E, F) RT-qPCR for mRNA of Beclin-1 (E) and miR-129-5p 
(F). *p<0.05. NS: non-significant. N=5.
Figure 5. Schematic of the model. The failure of ath-
erosclerosis-associated endothelial cell autophagy 
may result from HFD-induced downregulation of Be-
clin-1, through increased miR-129-5p that binds and 
suppresses translation of Beclin-1 mRNA.
MiR-129-5p-regulated Beclin-1 in AS-related EC autophagy 
1892 Am J Transl Res 2016;8(4):1886-1894
ings in HFD on mice. Thus, our study suggest 
that the failure of atherosclerosis-associated 
endothelial cell autophagy may result from 
HFD-induced downregulation of Beclin-1, 
through increased miR-129-5p that binds and 
suppresses translation of Beclin-1 mRNA 
(Figure 5).
Discussion
Atherosclerosis is a complex immune-inflam-
matory disease involving arteries of medium-
to-large size and its pathogenesis is coordinat-
ed among endothelial cells, macrophages and 
smooth muscle cells. First of all, injury of the 
vascular endothelium is a proven initial step in 
the pathogenesis of atherosclerosis. High glu-
cose is a potent pro-atherosclerotic factor that 
has been widely used to induce experimental 
atherosclerosis in vivo, while in vivo application 
of ox-LDL is able to cause endothelial cell injury 
that is observed during development of 
atherosclerosis. 
Aberrantly expressed miRNAs have recently 
been found to be involved in the development 
of endothelial cell survival/death, supported by 
many recent reports. Specially, Pan et al. 
reported that cardiomyocyte autophagy was 
regulated by Beclin-1 and miR-129-5p in cardi-
ac disease model. They used a dual luciferase 
reporter assay to confirm that Beclin-1 was a 
target gene of miR-129-5pa. These previous 
studies encouraged us to examine a possible 
role of miRNAs in the development of athero-
sclerosis through modulation of autophagy-
related proteins. 
Here, we found that HFD significantly impaired 
endothelia cell autophagy, and this failure of 
autophagy significantly increased endothelial 
cell death, through augment in cell apoptosis. 
Importantly, we found that Beclin-1 was the 
effector protein as a target of HFD, and most 
interestingly, its protein but not mRNA was 
changed by HFD. Of note, here the seemingly 
slight increases in mRNA (not reaching signifi-
cance) may be resulting from a feedback of 
requirement of increasing the protein levels 
that continuously failed. Since it is unlikely that 
Beclin-1 may be regulated by phosphorylation 
or acetylation in our experimental setting, we 
hypothesized that it might be regulated by 
miRNAs. 
All Beclin-1-targeting miRNAs were then deter-
mined by bioinformatics analyses, and we 
screened all these miRNAs and found that miR-
129-5p levels significantly increased in CD31+ 
endothelial cells from HFD mice. In addition, we 
used an in vitro atherosclerosis model to con-
firm this model in endothelial cell apoptosis.
Previous studies have shown controversy on 
the exact role of autophagy in the heart under 
pathological conditions [40]. Moreover, some 
of these studies have demonstrated seemingly 
different results from our work [41-46]. 
However, we think that these seemingly contra-
dictory data are actually reflections of the com-
plexity of autophagy in the regulation of devel-
opment of atherosclerosis. Since autophagy 
could be a double-edged sword, in which mod-
est levels of autophagy could improve the sur-
vival of the cells under insults, while the aug-
ment of autophagy level could lead to 
autophagy-associated cell death. Moreover, 
the differences in the exact HFD protocols, 
mouse strains (here ApoE-knockout mice), 
doses and frequency of ox-LDL, and analyzed 
target cells (here purified endothelial cells rath-
er than mixed cell types in some studies) may 
modify the relative levels of autophagy- and 
apoptosis- associated proteins in various stud-
ies, leading to seemingly paradoxical results. 
Nevertheless, these studies demonstrate a 
delicate control of the levels of autophagy may 
be crucial for the development of ather- 
osclerosis. 
Together, our study identified a new role for 
miR-129-5p in the regulation of endothelial cell 
autophagy during atherosclerosis, and shed 
new insight into development of innovative 
therapy by targeting miR-129-5p in atheroscle-
rosis treatment.
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